Selected Publications
Reciprocal effective conductance-based inference of protein-protein relationships delineates protein network hubs and macromolecular properties Rajendra K C, Sihang Zhou, Ruiying Cheng, Marco Andres Penaherrera, Simón Lizarazo, Kevin Van Bortle. bioRxiv (preprint) 2026
The NuRD complex shapes RNA polymerase III activity at highly expressed tRNA gene clusters, tuning the dynamic range of cellular tRNA pools Ruiying Cheng, Rajendra K C, Simón Lizarazo, Junmeng Yuan, Sihang Zhou, Saindhabi Ghosh, Kevin Van Bortle. Cell Reports 2026
An RNA polymerase III tissue and tumor atlas uncovers context-specific activities linked to 3D epigenome regulatory mechanisms Simón Lizarazo, Sihang Zhou, Ruiying Cheng, Rajendra K C, Saindhabi Ghosh, Yawei Shen, Qing Liu*, Kevin Van Bortle*. Genome Res. 2026
Cancer-associated snaR-A noncoding RNA interacts with core splicing machinery and disrupts processing of mRNA subpopulations Sihang Zhou, Simón Lizarazo, Sandip Chorghade, Leela Mouli, Ruiying Cheng, Rajendra K C, Auinash Kalsotra, Kevin Van Bortle. Nature Commun. 2025
Evidence of RNA polymerase III recruitment and transcription at protein-coding gene promoters Rajendra K C, Ruiying Cheng, Sihang Zhou, Simón Lizarazo, Duncan Smith, Kevin Van Bortle. Mol Cell. 2024
A combinatorial regulatory platform determines expression of RNA polymerase III subunit RPC7alpha (POLR3G) in cancer Ruiying Cheng*, Sihang Zhou*, Rajendra K C‡ , Simón Lizarazo‡ , Leela Mouli, Anshita Jayanth, Qing Liu, Kevin Van Bortle. Cancers. 2023
The Pol III transcriptome: Basic features, recurrent patterns, and emerging roles in cancer Sihang Zhou, Kevin Van Bortle. Wiley Interdiscip Rev RNA. 2023
RNA polymerase III transcription and cancer: A tale of two RPC7 subunits Ruiying Cheng, Kevin Van Bortle. Front Mol Biosci. 2023